Wiik P, Opstad P K, Bøyum A
Regul Pept. 1985 Oct;12(2):145-53. doi: 10.1016/0167-0115(85)90195-8.
Vasoactive intestinal polypeptide (VIP) interaction with a 94% pure preparation of monocytes isolated from human peripheral blood was studied by direct binding technique using 3-[125I]tyrosyl-VIP as a tracer ligand. Scatchard analysis of binding data was compatible with two classes of binding sites, one with Kd = 0.25 nM and maximal binding capacity of 16 fmol/10(6) cells, and another one with Kd = 25 nM and maximal binding capacity of 180 fmol/10(6) cells. The binding was time-, temperature-, and pH-dependent and was saturable, reversible, and specific. This study has demonstrated that human monocytes have high affinity/low capacity as well as low affinity/high capacity binding sites for VIP. No specific VIP binding was found in pure preparations of human granulocytes, platelets or erythrocytes.
采用直接结合技术,以3-[¹²⁵I]酪氨酸 - 血管活性肠肽(VIP)作为示踪配体,研究了血管活性肠肽(VIP)与人外周血分离的94%纯度单核细胞制剂的相互作用。结合数据的Scatchard分析符合两类结合位点,一类Kd = 0.25 nM,最大结合容量为16 fmol/10⁶个细胞,另一类Kd = 25 nM,最大结合容量为180 fmol/10⁶个细胞。这种结合具有时间、温度和pH依赖性,且具有饱和性、可逆性和特异性。本研究表明,人单核细胞对VIP具有高亲和力/低容量以及低亲和力/高容量的结合位点。在人粒细胞、血小板或红细胞的纯制剂中未发现特异性VIP结合。